Evidence of an immunologic mechanism behind the therapeutical effects of arsenic trioxide (As2O3) on myeloma cells. Commentary

Saved in:
Bibliographic Details
Published inLeukemia research Vol. 25; no. 3; pp. 227 - 239
Main Authors DEAGLIO, Silvia, CANELLA, Donatella, BAJ, Germano, ARNULFO, Alberto, WAXMAN, Samuel, MALAVASI, Fabio, GALLAGHER, Robert E
Format Journal Article
LanguageEnglish
Published Oxford Elsevier Science 2001
Subjects
Antineoplastic agents
Biological and medical sciences
General aspects
Medical sciences
Pharmacology. Drug treatments
Antineoplastic agent
Human
Immunopathology
Biological marker
Arsenic trioxide
Cytotoxicity
Malignant hemopathy
Myeloma
Adhesion
In vitro
Cell differentiating agent
Immunoglobulinopathy
Lymphoproliferative syndrome
LAK cell
Established cell line
Mechanism of action
Lymphocyte
Immune system
Online AccessGet full text

Cover

More Information
ISSN:0145-2126
1873-5835